ArticleInflammatory bowel diseases2026
Disease Outcomes After Segmental Resection of Colonic Crohn's Disease: A Retrospective Multicenter Study.
Article in Inflammatory bowel diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundColonic surgery for Crohn's disease (CD) frequently involves sparing uninvolved segments of the colon. Few studies have assessed recurrence rates after segmental colectomy (SC). The aim of this study was to determine the rate of and identify the risk factors for postoperative CD recurrence.
methodsThis was a multicenter retrospective study from 3 tertiary inflammatory bowel disease (IBD) referral centers of CD patients who underwent SC between 2000 and 2019. We defined endoscopic recurrence as the presence of ulcers in the remaining colon upon postoperative colonoscopy.
resultsA total of 108 patients were included. Sixty-nine (63.9%) patients had evidence of postoperative CD endoscopic recurrence. Age at surgery <40 years and disease duration ≤156 months predicted an increased likelihood for postoperative recurrence (odds ratio [OR], 2.43; P = .031 and OR, 3.29; P = .005, respectively), whereas abdominal perineal resection (OR, 0.21; P = .005), indication for SC of malignancy (OR, 0.14; P = .016), and postoperative use of tumor necrosis factor α (TNFα) inhibitor for prophylactic purposes (OR, 0.38; P = .040) negatively predicted disease recurrence. Disease duration ≤156 months (OR, 2.86; P = .039) and postoperative TNFα inhibitor prophylaxis remained significant (OR, 0.26; P = .013) upon multivariable modeling.
conclusionAlthough high rates of recurrence persist within the postoperative phase of SC for CD, the postoperative use of TNFα inhibitor for prophylactic purposes for a subset of patients may promote a more durable endoscopic remission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.